75
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Assessment of the effects of glutamic acid decarboxylase antibodies and trace elements on cognitive performance in older adults

, &
Pages 1901-1907 | Published online: 03 Dec 2015

References

  • MiddletonLEBarnesDELuiLYaffeKPhysical activity over the life course and its association with cognitive performance and impairment in old ageJ Am Geriatr Soc20105871322132620609030
  • JosmanNAbdallahTMEngel-YegerBUsing the LOTCA to measure cultural and sociodemographic effects on cognitive skills in two groups of childrenAm J Occup Ther201165293721309369
  • GradyCThe cognitive neuroscience of ageingNat Rev Neurosci201213749150522714020
  • AlbertMSDeKoskySTDicksonDThe diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimer’s Dement20117327027921514249
  • RoyallDRPalmerRChiodoLKPolkMJNormal rates of cognitive change in successful aging: the freedom house studyJ Int Neuropsychol Soc20051189990916519269
  • Stine-MorrowEALParisiJMMorrowDGParkDCThe effects of an engaged lifestyle on cognitive vitality: a field experimentPsychol Aging200823477878619140649
  • AttiARForlaniCDe RonchiDPalmerKCasadioPDalmonteECognitive impairment after age 60: clinical and social correlates in the “Faenza Project”J Alzheimer’s Dis20102141325133421504137
  • WhitsonHEAnsahDWhitakerDPrevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular diseaseArch Gerontol Geriatr201050220921219427045
  • SongFPoljakASmytheGASachdevPPlasma biomarkers for mild cognitive impairment and Alzheimer’s diseaseBrain Res Rev2009612698019464319
  • LovellMAMarkesberyWROxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s diseaseNucleic Acids Res20073522749750417947327
  • ButterfieldDASultanaRRedox proteomics identification of oxida-tively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorderJ Alzheimer’s Dis2007121617217851195
  • PraticoDAlzheimer’s disease and oxygen radicals: new insightsBiochem Pharmacol20026356356711992623
  • DosunmuRWuJBashaMRZawiaNHEnvironmental and dietary risk factors in Alzheimer’s diseaseExpert Rev Neurotherap200777887900
  • SilvestriLCamaschellaCApotential pathogenetic role of iron in Alzeimer’s DiseaseJ Cell Mol Med200851
  • LauFCShukitt-HaleBJosephJANutritional intervention in brain aging: reducing the effects of inflammation and oxidative stressSubcell Biochem20074229931817612057
  • ColeGMLimGPYangFPrevention of Alzheimer’s disease: Omega-3 fatty acid and phenolic anti-oxidant interventionsNeurobiol Aging200526Suppl 113313616266772
  • GardeEMortensenELKrabbeKRostrupELarssonHBWRelation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal studyLancet200035662863410968435
  • De GrootJCDe LeeuwFEOudkerkMGijnJVHofmanAJollesJPeriventricular cerebral white matter lesions predict rate of cognitive declineAnn Neurol20025233534112205646
  • CobbSRBuhlEHHalasyKPaulsenOSomogyiPSynchronization of neuronal activity in hippocampus by individual GABAergic interneuronsNature199537875787477292
  • SaizABlancoYSabaterLSpectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this associationBrain20081312553256318687732
  • AliFRowleyMJayakrishnanBTeuberSGershwinMEMackayIRStiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathiesJ Autoimmun201137798721680149
  • TinsleyJABarthEMBlackJLWilliamsDEPsychiatric consultations in stiff-man syndromeJ Clin Psychiatry1997584444499375596
  • SaidhaSMurphySRonayneAMcCarthyPHennessyMJCounihanTTreatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetilJ Neurol20102571035103820130897
  • BlackJLBarthEMWilliamsDETinsleyJAStiff-man syndrome. Results of interviews and psychologic testingPsychosomatics19983938449538674
  • AlmomaniFJosmanNAlmomaniMOFactors related to cognitive function among elementary school childrenScand J Occup Ther20142119119824215566
  • ItzkovichMElazarBAverbuchSLoewenstein Occupational Therapy Cognitive Assessment (LOTCA) manual2nd ed Printed in USAOccupational Therapy Department, Loewenstein Rehabilitation Hospital, IsraelMaddac2000
  • BullFCMaslinTSArmstrongTGlobal physical activity questionnaire (GPAQ): nine country reliability and validity studyJ Phys Act Health2009679080420101923
  • TrinhOTHNguyenNDvan der PloegHPDibleyMJBaumanATest-retest repeatability and relative validity of the Global Physical Activity Questionnaire in a developing country contextJ Phys Act Health20096S46S5319998849
  • SchroderJKratzBPantelJMinnemannELehrUSauerHPrevalence of mild cognitive impairment in an elderly community sampleJ Neural Transm Suppl19985451599850914
  • UnverzagtFWGaoSBaiyewuOPrevalence of cognitive impairment: data from the Indianapolis Study of Health and AgingNeurology2001571655166211706107
  • VellasBLauqueSAndrieuSNutrition assessment in the elderlyCurr Opin Clin Nutr Metab Care200145811122552
  • EkmekciogluCThe role of trace elements for the health of elderly individualsNahrung20014530931611715341
  • GlymourMMManlyJJLifecourse social conditions and racial and ethnic patterns of cognitive agingNeuropsychol Rev20081822325410.1007/s11065-008-9064-z18815889
  • Zeki Al HazzouriAHaanMNOsypukTAbdouCHintonLAielloAENeighborhood socioeconomic context and cognitive decline among older Mexican Americans: results from the Sacramento Area Latino Study on AgingAm J Epidemiol201117442343121715645
  • ArcherTGarciaDPhysical exercise influences academic performance and well-being in children and adolescentsInt J School Cogn Psychol20141e102
  • DuntonGFHuhJLeventhalAMMomentary assessment of affect, physical feeling states, and physical activity in childrenHealth Psychol201433325526323668846
  • WoodardJLSugarmanMANielsonKALifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy agingCurr Alzheimer Res20129443644622272622
  • ChangYKNienYHTasiCLEtnierJLPhysical activity and cognition in older adults: the potential of Tai Chi ChuanJ Aging Phys Activity201018451472
  • JacobsonAMMusenGRyanCMLong-term effect of diabetes and its treatment on cognitive functionNew Engl J Med2007356181842185217476010
  • Cukierman-YaffeTGersteinHCWilliamsonJDRelationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factorsDiabetes Care200932222122619171735
  • ReijmerYDvan den BergERuisCKappelleLJBiesselsGJCognitive dysfunction in patients with type 2 diabetesDiabetes/Metab Res Rev2010267507519
  • PizziCManzoliLManciniSCostaGMAnalysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial functionEur Heart J20082991110111718400765
  • SweilehWMAbu-HadeedHMAl-JabiSWZyoudSHPrevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in PalestineBMC Public Health201414116324524353
  • MaylorEAReimersSChoiJCollaerMLPetersMSilvermanIGender and sexual orientation differences in cognition across adulthood: age is kinder to women than to men regardless of sexual orientationArch Sex Behav200736223524917351741
  • TripathiRKumarKBharathSMarimuthuPVargheseMAge, education and gender effects on neuropsychological functions in healthy Indian older adultsDement Neuropsychol201482148154
  • PetersenRCRobertsROKnopmanDSPrevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of AgingNeurology2010751088989720820000
  • DalakasMCLiMFujiiMJacobowitzDMStiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodiesNeurology20015778078411552003
  • OrtegaRMRequejoAMAndresPDietary intake and cognitive function in a group of elderly peopleAm J Clin Nutr1997668038099322553
  • MorrisMCEvansDATangneyCCDietary copper and high saturated and trans fat intakes associated with cognitive declineArch Neurol2006631085108816908733
  • SquittiRBarbatiGRossiLExcess of non ceruloplasmin serum copper in AD correlates with MMSE, CSF (beta)-amyloid, and h-tauNeurology200667768216832081
  • HuangXCuajungcoMPAtwoodCSCu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reductionJ Biol Chem1999274371113711610601271
  • SquittiRRossiniPMCassettaED-penicillamine reduces serum oxidative stress in Alzheimer’s disease patientsEur J Clin Invest200232515911851727
  • CuajungcoMPFagetKYZinc takes the center stage: its paradoxical role in Alzheimer’s diseaseBrain Res Brain Res Rev200341445612505647
  • ThompsonKJShohamSConnorJRIron and neurodegenerative disordersBrain Res Bull20015515516411470311
  • YoudimMBBen ShacharDRiedererPIron in brain function and dysfunction with emphasis on Parkinson’s diseaseEur Neurol199131Suppl 134401649757
  • TurnlundJRCopperShilsMModern Nutrition in Health and DiseaseBaltimoreWilliams & Wilkins1999241252
  • SandsteadHHFredericksonCJPenlandJGHistory of zinc as related to brain functionJ Nutr2000130496S502S10721938
  • SquittiRLupoiDPasqualettiPElevation of serum copper levels in Alzheimer’s diseaseNeurology2002591153116112391342
  • FaberSZinnGMKernJC2ndKingstonHMThe plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disordersBiomarkers20091417118019280374
  • AschnerMSyversenTSouzaDORochaJBTMetallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicityExp Biol Med200623114681473
  • KhanMWSherwaniSKhanWAAliRCharacterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetesAutoimmunity20094215015819085183
  • LiQGuoMXuXRapid decrease of GAD 67 content before the convulsion induced by hyperbaric oxygen exposureNeurochem Res20083318519317712632
  • TrigwellSMRadfordPMPageSRIslet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitusClin Exp Immunol200112624224911703367